Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans

Kaohsiung Journal of Medical Sciences

Volumn 28, Issue 10, 2012, Pages 545-549

  Chen, Yi Ting ^a,b   Chen, Wan Tzu ^a   Huang, Wan Ting ^a   Wu, Chun Chieh ^a   Chai, Chee Yin ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Dermatofibroma; Dermatofibrosarcoma protuberans; MMP 11; MMP 2; MMP 9

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8A; CD34 ANTIGEN; GELATINASE A; GELATINASE B; SCLEROPROTEIN; STROMELYSIN 3;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PATHOGENESIS; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN FIBROBLAST;

ANTIGENS, CD34; DERMATOFIBROSARCOMA; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 11; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PARAFFIN EMBEDDING;

EID: 84867888788     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2012.04.017     Document Type: Article

References (29)

1. D.M. Weinrach, K.L. Wang, E.L. Wiley, and W.B. Laskin Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma) Arch Pathol Lab Med 128 2004 1136 1141
2. S. Otani, H. Ishii, K. Hashinaga, R. Morinaga, K. Umeki, and K. Kishi [Pulmonary metastasis of fibrosarcomatous variant of dermatofibrosarcoma protuberans: case report and review of literature] Nihon Kokyuki Gakkai Zasshi 46 2008 253 257
3. P. Abenoza, and T. Lillemoe CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans Am J Dermatopathol 15 1993 429 434
4. J.R. Goldblum, and R.J. Tuthill CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma Am J Dermatopathol 19 1997 147 153
5. P.R. Cohen, R.P. Rapin, and A.I. Farhood Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa Am J Dermatopathol 16 1994 573 574
6. N. Adler, C. Tsabari, J. Sulkes, D. Ad-El, and M. Feinmesser Cyclooxygenase-2 expression in dermatofibroma and dermatofibrosarcoma protuberans J Cutan Pathol 35 2008 532 535
7. S. Labonte, W. Hanna, and B. Bandarchi-Chamkhaleh A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma J Cutan Pathol 34 2007 857 860
8. T. Mori, N. Misago, O. Yamamoto, S. Toda, and Y. Narisawa Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma J Dermatol 35 2008 419 425
9. R.B. West, J. Harvell, S.C. Linn, C.L. Liu, W. Prapong, and T. Hernandez-Boussard Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans Am J Surg Pathol 28 2004 1063 1069
10. N. Li, J. McNiff, P. Hui, G. Manfioletti, and G. Tallini Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity Am J Dermatopathol 26 2004 267 272
11. I. Stamenkovic Extracellular matrix remodelling: the role of matrix metalloproteinases J Pathol 200 2003 448 464
12. K.J. Heppner, L.M. Matrisian, R.A. Jensen, and W.H. Rodgers Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response Am J Pathol 149 1996 273 282
13. P.E. LeBoit, G. Burg, D. Weedon, and A. Sarasin Pathology and genetics of tumors of the skin tumours 2006 IARC Lyon
14. H.J. Kim, J.Y. Lee, S.H. Kim, Y.J. Seo, J.H. Lee, and J.K. Park Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34 Br J Dermatol 157 2007 319 324
15. E. Calikoglu, E. Augsburger, P. Chavaz, J.H. Saurat, and G. Kaya CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans J Cutan Pathol 30 2003 185 189
16. B. Bandarchi, L. Ma, C. Marginean, S. Hafezi, J. Zubovits, and G. Rasty D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans Mod Pathol 23 2010 434 438
17. R. Sachdev, and U. Sundram Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa J Cutan Pathol 33 2006 353 360
18. H. Dominguez-Malagon, C. Valdez-Carrillo Mdel, and A.M. Cano-Valdez Dermatofibroma and dermatofibrosarcoma protuberans: a comparative ultrastructural study Ultrastruct Pathol 30 2006 283 291
19. R. Vanni, S. Marras, G. Faa, S. Licheri, G.M. Daniele, and C.D. Fletcher Cellular fibrous histiocytoma of the skin: evidence of a clonal process with different karyotype from dermatofibrosarcoma Genes Chromosomes Cancer 18 1997 314 317
20. M. Sasaki, T. Ishida, H. Horiuchi, and R. MacHinami Dermatofibrosarcoma protuberans: an analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression Pathol Int 49 1999 799 806
21. Y. Xiong, H. Guo, S. Zhang, B. Zhang, and T. Li Differences of the molecular phenotypes and the histogenesis between dermatofibroma and dermatofibrosarcoma protuberans Beijing Da Xue Xue Bao 40 2008 395 400
22. A. Schutz, D. Schneidenbach, G. Aust, A. Tannapfel, M. Steinert, and C. Wittekind Differential expression and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung Tumour Biol 23 2002 179 184
23. R.R. Baruch, H. Melinscak, J. Lo, Y. Liu, O. Yeung, and R.A. Hurta Altered matrix metalloproteinase expression associated with oncogene-mediated cellular transformation and metastasis formation Cell Biol Int 25 2001 411 420
24. B. Cribier, G. Noacco, B. Peltre, and E. Grosshans Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans J Am Acad Dermatol 46 2002 408 413
25. Y. Soini, T. Salo, A. Oikarinen, and H. Autio-Harmainen Expression of 72 kilodalton and 92 kilodalton type IV collagenase in malignant fibrous histiocytomas and dermatofibromas Lab Invest 69 1993 305 311
26. T. Hurskainen, Y. Soini, A. Tuuttila, M. Hoyhtya, A. Oikarinen, and H. Autio-Harmainen Expression of the tissue metalloproteinase inhibitors TIMP-1 and TIMP-2 in malignant fibrous histiocytomas and dermatofibromas as studied by in situ hybridization and immunohistochemistry Hum Pathol 27 1996 42 49
27. A.B. Unden, B. Sandstedt, K. Bruce, M. Hedblad, and M. Stahle-Backdahl Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma J Invest Dermatol 107 1996 147 153
28. M. Thewes, W.I. Worret, R. Engst, and J. Ring Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders Clin Exp Dermatol 24 1999 122 126
29. Y. Ohnishi, Y. Ito, S. Tajima, A. Ishibashi, and K. Arai Immunohistochemical study of membrane type-matrix metalloproteinases (MT-MMPs) and matrix metalloproteinase-2 (MMP-2) in dermatofibroma and malignant fibrous histiocytoma J Dermatol Sci 28 2002 119 125